The global market for Suvorexant API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Suvorexant API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Suvorexant, sold under the brand name Belsomra, is an orexin antagonist drug used to treat insomnia. It is specifically designed to treat insomnia characterized by difficulty falling or staying asleep in adults, helping to fall asleep faster, stay asleep longer, wake up less often in the middle of the night, and achieve better quality sleep.

The Suvorexant API industry chain consists of upstream fine chemicals and key pharmaceutical intermediates, midstream API synthesis and crystal form control, and downstream formulation companies and end-user applications. Downstream demand is concentrated in formulation companies producing novel mechanism drugs for insomnia and large prescription drug retailers. These companies leverage their clinical, brand, and channel advantages to promote the use of Suvoresin formulations in hospitals and specialized sleep medicine institutions. Within the downstream structure, the growth rate of demand from formulation companies far exceeds that of upstream capacity expansion, making it the core driving force for industry scale expansion. Simultaneously, hospital systems, internet healthcare, and chain pharmacies have improved prescription accessibility, resulting in a stable upward trend in API demand.

The development trend of Suvoresin API is driven by the increasing global demand for insomnia treatment, the substitution of non-benzodiazepine drugs, policy support for low-dependency drugs, and the continued recognition of innovative mechanisms. With the increasing specialization of sleep medicine and patients' growing concern for safety, dual orexin receptor antagonist products maintain rapid growth in many countries. Downstream formulation companies' continuous expansion of indications and accelerated international registration will further increase their procurement of APIs. Obstacles remain, including complex active pharmaceutical ingredient (API) synthesis routes, high costs, relatively concentrated supply of core intermediates, difficulty in controlling crystal form consistency, long market entry cycles in some markets, and slow shifts in physician prescribing habits. Awareness of these drugs in emerging markets such as Southeast Asia and the Middle East also needs improvement, resulting in uneven regional penetration.

In 2024, the production volume of Suvorexant API was 448 kg, with an average price of US$22,400/kg and a gross profit margin typically ranging from 45% to 60%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Suvorexant API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Suvorexant API.

The Suvorexant API market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Suvorexant API market comprehensively. Regional market sizes, concerning products by Type, by Application, by Synthesis Method and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Suvorexant API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Synthesis Method and by regions.

Scope of Suvorexant API Market Report

Report Metric	Details
Report Name	Suvorexant API Market
Segment by Type	Industrial Grade (98%-99.0%) Pharmaceutical Grade (99.0%-99.5%) High Purity Grade (Greater Than 99.5%)
Segment by Synthesis Method	Fragment Splicing Method Linear Synthesis Method
Segment by Drug Registration Classification	Original Drug Generic Drug
Segment by Application	Insomnia Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Biophore, Metrochem, Alembic Pharmaceuticals, Bajaj Healthcare, DEAFARMA, LifeFirst Pharma, Saptagir Laboratories, SMS Pharmaceuticals, Viatris, Zydus Lifesciences, Axplora, Apino Pharma, Conscientia Industrial, BSAZ Biotech, Sandoo Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, by Synthesis Method etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Suvorexant API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Suvorexant API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Suvorexant API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Suvorexant API Market report?

Ans: The main players in the Suvorexant API Market are Merck, Biophore, Metrochem, Alembic Pharmaceuticals, Bajaj Healthcare, DEAFARMA, LifeFirst Pharma, Saptagir Laboratories, SMS Pharmaceuticals, Viatris, Zydus Lifesciences, Axplora, Apino Pharma, Conscientia Industrial, BSAZ Biotech, Sandoo Pharmaceutical

What are the Application segmentation covered in the Suvorexant API Market report?

Ans: The Applications covered in the Suvorexant API Market report are Insomnia, Others

What are the Type segmentation covered in the Suvorexant API Market report?

Ans: The Types covered in the Suvorexant API Market report are Industrial Grade (98%-99.0%), Pharmaceutical Grade (99.0%-99.5%), High Purity Grade (Greater Than 99.5%)

1 Suvorexant API Market Overview

1.1 Product Definition

1.2 Suvorexant API by Type

1.2.1 Global Suvorexant API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Industrial Grade (98%-99.0%)

1.2.3 Pharmaceutical Grade (99.0%-99.5%)

1.2.4 High Purity Grade (Greater Than 99.5%)

1.3 Suvorexant API by Synthesis Method

1.3.1 Global Suvorexant API Market Value Growth Rate Analysis by Synthesis Method: 2024 VS 2031

1.3.2 Fragment Splicing Method

1.3.3 Linear Synthesis Method

1.4 Suvorexant API by Drug Registration Classification

1.4.1 Global Suvorexant API Market Value Growth Rate Analysis by Drug Registration Classification: 2024 VS 2031

1.4.2 Original Drug

1.4.3 Generic Drug

1.5 Suvorexant API by Application

1.5.1 Global Suvorexant API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.5.2 Insomnia

1.5.3 Others

1.6 Global Market Growth Prospects

1.6.1 Global Suvorexant API Production Value Estimates and Forecasts (2020-2031)

1.6.2 Global Suvorexant API Production Capacity Estimates and Forecasts (2020-2031)

1.6.3 Global Suvorexant API Production Estimates and Forecasts (2020-2031)

1.6.4 Global Suvorexant API Market Average Price Estimates and Forecasts (2020-2031)

1.7 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Suvorexant API Production Market Share by Manufacturers (2020-2025)

2.2 Global Suvorexant API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Suvorexant API, Industry Ranking, 2023 VS 2024

2.4 Global Suvorexant API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Suvorexant API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Suvorexant API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Suvorexant API, Product Offered and Application

2.8 Global Key Manufacturers of Suvorexant API, Date of Enter into This Industry

2.9 Suvorexant API Market Competitive Situation and Trends

2.9.1 Suvorexant API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Suvorexant API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Suvorexant API Production by Region

3.1 Global Suvorexant API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Suvorexant API Production Value by Region (2020-2031)

3.2.1 Global Suvorexant API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Suvorexant API by Region (2026-2031)

3.3 Global Suvorexant API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Suvorexant API Production Volume by Region (2020-2031)

3.4.1 Global Suvorexant API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Suvorexant API by Region (2026-2031)

3.5 Global Suvorexant API Market Price Analysis by Region (2020-2025)

3.6 Global Suvorexant API Production and Value, Year-over-Year Growth

3.6.1 North America Suvorexant API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Suvorexant API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Suvorexant API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Suvorexant API Production Value Estimates and Forecasts (2020-2031)

4 Suvorexant API Consumption by Region

4.1 Global Suvorexant API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Suvorexant API Consumption by Region (2020-2031)

4.2.1 Global Suvorexant API Consumption by Region (2020-2025)

4.2.2 Global Suvorexant API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Suvorexant API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Suvorexant API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Netherlands

4.5 Asia Pacific

4.5.1 Asia Pacific Suvorexant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Suvorexant API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Suvorexant API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Suvorexant API Production by Type (2020-2031)

5.1.1 Global Suvorexant API Production by Type (2020-2025)

5.1.2 Global Suvorexant API Production by Type (2026-2031)

5.1.3 Global Suvorexant API Production Market Share by Type (2020-2031)

5.2 Global Suvorexant API Production Value by Type (2020-2031)

5.2.1 Global Suvorexant API Production Value by Type (2020-2025)

5.2.2 Global Suvorexant API Production Value by Type (2026-2031)

5.2.3 Global Suvorexant API Production Value Market Share by Type (2020-2031)

5.3 Global Suvorexant API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Suvorexant API Production by Application (2020-2031)

6.1.1 Global Suvorexant API Production by Application (2020-2025)

6.1.2 Global Suvorexant API Production by Application (2026-2031)

6.1.3 Global Suvorexant API Production Market Share by Application (2020-2031)

6.2 Global Suvorexant API Production Value by Application (2020-2031)

6.2.1 Global Suvorexant API Production Value by Application (2020-2025)

6.2.2 Global Suvorexant API Production Value by Application (2026-2031)

6.2.3 Global Suvorexant API Production Value Market Share by Application (2020-2031)

6.3 Global Suvorexant API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Merck

7.1.1 Merck Suvorexant API Company Information

7.1.2 Merck Suvorexant API Product Portfolio

7.1.3 Merck Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Merck Main Business and Markets Served

7.1.5 Merck Recent Developments/Updates

7.2 Biophore

7.2.1 Biophore Suvorexant API Company Information

7.2.2 Biophore Suvorexant API Product Portfolio

7.2.3 Biophore Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Biophore Main Business and Markets Served

7.2.5 Biophore Recent Developments/Updates

7.3 Metrochem

7.3.1 Metrochem Suvorexant API Company Information

7.3.2 Metrochem Suvorexant API Product Portfolio

7.3.3 Metrochem Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Metrochem Main Business and Markets Served

7.3.5 Metrochem Recent Developments/Updates

7.4 Alembic Pharmaceuticals

7.4.1 Alembic Pharmaceuticals Suvorexant API Company Information

7.4.2 Alembic Pharmaceuticals Suvorexant API Product Portfolio

7.4.3 Alembic Pharmaceuticals Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Alembic Pharmaceuticals Main Business and Markets Served

7.4.5 Alembic Pharmaceuticals Recent Developments/Updates

7.5 Bajaj Healthcare

7.5.1 Bajaj Healthcare Suvorexant API Company Information

7.5.2 Bajaj Healthcare Suvorexant API Product Portfolio

7.5.3 Bajaj Healthcare Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Bajaj Healthcare Main Business and Markets Served

7.5.5 Bajaj Healthcare Recent Developments/Updates

7.6 DEAFARMA

7.6.1 DEAFARMA Suvorexant API Company Information

7.6.2 DEAFARMA Suvorexant API Product Portfolio

7.6.3 DEAFARMA Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 DEAFARMA Main Business and Markets Served

7.6.5 DEAFARMA Recent Developments/Updates

7.7 LifeFirst Pharma

7.7.1 LifeFirst Pharma Suvorexant API Company Information

7.7.2 LifeFirst Pharma Suvorexant API Product Portfolio

7.7.3 LifeFirst Pharma Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 LifeFirst Pharma Main Business and Markets Served

7.7.5 LifeFirst Pharma Recent Developments/Updates

7.8 Saptagir Laboratories

7.8.1 Saptagir Laboratories Suvorexant API Company Information

7.8.2 Saptagir Laboratories Suvorexant API Product Portfolio

7.8.3 Saptagir Laboratories Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Saptagir Laboratories Main Business and Markets Served

7.8.5 Saptagir Laboratories Recent Developments/Updates

7.9 SMS Pharmaceuticals

7.9.1 SMS Pharmaceuticals Suvorexant API Company Information

7.9.2 SMS Pharmaceuticals Suvorexant API Product Portfolio

7.9.3 SMS Pharmaceuticals Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 SMS Pharmaceuticals Main Business and Markets Served

7.9.5 SMS Pharmaceuticals Recent Developments/Updates

7.10 Viatris

7.10.1 Viatris Suvorexant API Company Information

7.10.2 Viatris Suvorexant API Product Portfolio

7.10.3 Viatris Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Viatris Main Business and Markets Served

7.10.5 Viatris Recent Developments/Updates

7.11 Zydus Lifesciences

7.11.1 Zydus Lifesciences Suvorexant API Company Information

7.11.2 Zydus Lifesciences Suvorexant API Product Portfolio

7.11.3 Zydus Lifesciences Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Zydus Lifesciences Main Business and Markets Served

7.11.5 Zydus Lifesciences Recent Developments/Updates

7.12 Axplora

7.12.1 Axplora Suvorexant API Company Information

7.12.2 Axplora Suvorexant API Product Portfolio

7.12.3 Axplora Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Axplora Main Business and Markets Served

7.12.5 Axplora Recent Developments/Updates

7.13 Apino Pharma

7.13.1 Apino Pharma Suvorexant API Company Information

7.13.2 Apino Pharma Suvorexant API Product Portfolio

7.13.3 Apino Pharma Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Apino Pharma Main Business and Markets Served

7.13.5 Apino Pharma Recent Developments/Updates

7.14 Conscientia Industrial

7.14.1 Conscientia Industrial Suvorexant API Company Information

7.14.2 Conscientia Industrial Suvorexant API Product Portfolio

7.14.3 Conscientia Industrial Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Conscientia Industrial Main Business and Markets Served

7.14.5 Conscientia Industrial Recent Developments/Updates

7.15 BSAZ Biotech

7.15.1 BSAZ Biotech Suvorexant API Company Information

7.15.2 BSAZ Biotech Suvorexant API Product Portfolio

7.15.3 BSAZ Biotech Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.15.4 BSAZ Biotech Main Business and Markets Served

7.15.5 BSAZ Biotech Recent Developments/Updates

7.16 Sandoo Pharmaceutical

7.16.1 Sandoo Pharmaceutical Suvorexant API Company Information

7.16.2 Sandoo Pharmaceutical Suvorexant API Product Portfolio

7.16.3 Sandoo Pharmaceutical Suvorexant API Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Sandoo Pharmaceutical Main Business and Markets Served

7.16.5 Sandoo Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Suvorexant API Industry Chain Analysis

8.2 Suvorexant API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Suvorexant API Production Mode & Process Analysis

8.4 Suvorexant API Sales and Marketing

8.4.1 Suvorexant API Sales Channels

8.4.2 Suvorexant API Distributors

8.5 Suvorexant API Customer Analysis

9 Suvorexant API Market Dynamics

9.1 Suvorexant API Industry Trends

9.2 Suvorexant API Market Drivers

9.3 Suvorexant API Market Challenges

9.4 Suvorexant API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Metrochem

Merck

Biophore

Alembic Pharmaceuticals

Bajaj Healthcare

DEAFARMA

Saptagir Laboratories

Conscientia Industrial

Sandoo Pharmaceutical

LifeFirst Pharma

BSAZ Biotech

List of Tables

Table 1. Global Suvorexant API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Suvorexant API Market Value by Synthesis Method, (US$ Million) & (2024 VS 2031)

Table 3. Global Suvorexant API Market Value by Drug Registration Classification, (US$ Million) & (2024 VS 2031)

Table 4. Global Suvorexant API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 5. Global Suvorexant API Production Capacity (kg) by Manufacturers in 2024

Table 6. Global Suvorexant API Production by Manufacturers (2020-2025) & (kg)

Table 7. Global Suvorexant API Production Market Share by Manufacturers (2020-2025)

Table 8. Global Suvorexant API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 9. Global Suvorexant API Production Value Share by Manufacturers (2020-2025)

Table 10. Global Key Players of Suvorexant API, Industry Ranking, 2023 VS 2024

Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Suvorexant API as of 2024)

Table 12. Global Market Suvorexant API Average Price by Manufacturers (US$/kg) & (2020-2025)

Table 13. Global Key Manufacturers of Suvorexant API, Manufacturing Base Distribution and Headquarters

Table 14. Global Key Manufacturers of Suvorexant API, Product Offered and Application

Table 15. Global Key Manufacturers of Suvorexant API, Date of Enter into This Industry

Table 16. Global Suvorexant API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Mergers & Acquisitions, Expansion Plans

Table 18. Global Suvorexant API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Suvorexant API Production Value (US$ Million) by Region (2020-2025)

Table 20. Global Suvorexant API Production Value Market Share by Region (2020-2025)

Table 21. Global Suvorexant API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 22. Global Suvorexant API Production Value Market Share Forecast by Region (2026-2031)

Table 23. Global Suvorexant API Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)

Table 24. Global Suvorexant API Production (kg) by Region (2020-2025)

Table 25. Global Suvorexant API Production Market Share by Region (2020-2025)

Table 26. Global Suvorexant API Production (kg) Forecast by Region (2026-2031)

Table 27. Global Suvorexant API Production Market Share Forecast by Region (2026-2031)

Table 28. Global Suvorexant API Market Average Price (US$/kg) by Region (2020-2025)

Table 29. Global Suvorexant API Market Average Price (US$/kg) by Region (2026-2031)

Table 30. Global Suvorexant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)

Table 31. Global Suvorexant API Consumption by Region (2020-2025) & (kg)

Table 32. Global Suvorexant API Consumption Market Share by Region (2020-2025)

Table 33. Global Suvorexant API Forecasted Consumption by Region (2026-2031) & (kg)

Table 34. Global Suvorexant API Forecasted Consumption Market Share by Region (2026-2031)

Table 35. North America Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)

Table 36. North America Suvorexant API Consumption by Country (2020-2025) & (kg)

Table 37. North America Suvorexant API Consumption by Country (2026-2031) & (kg)

Table 38. Europe Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)

Table 39. Europe Suvorexant API Consumption by Country (2020-2025) & (kg)

Table 40. Europe Suvorexant API Consumption by Country (2026-2031) & (kg)

Table 41. Asia Pacific Suvorexant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)

Table 42. Asia Pacific Suvorexant API Consumption by Region (2020-2025) & (kg)

Table 43. Asia Pacific Suvorexant API Consumption by Region (2026-2031) & (kg)

Table 44. Latin America, Middle East & Africa Suvorexant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)

Table 45. Latin America, Middle East & Africa Suvorexant API Consumption by Country (2020-2025) & (kg)

Table 46. Latin America, Middle East & Africa Suvorexant API Consumption by Country (2026-2031) & (kg)

Table 47. Global Suvorexant API Production (kg) by Type (2020-2025)

Table 48. Global Suvorexant API Production (kg) by Type (2026-2031)

Table 49. Global Suvorexant API Production Market Share by Type (2020-2025)

Table 50. Global Suvorexant API Production Market Share by Type (2026-2031)

Table 51. Global Suvorexant API Production Value (US$ Million) by Type (2020-2025)

Table 52. Global Suvorexant API Production Value (US$ Million) by Type (2026-2031)

Table 53. Global Suvorexant API Production Value Market Share by Type (2020-2025)

Table 54. Global Suvorexant API Production Value Market Share by Type (2026-2031)

Table 55. Global Suvorexant API Price (US$/kg) by Type (2020-2025)

Table 56. Global Suvorexant API Price (US$/kg) by Type (2026-2031)

Table 57. Global Suvorexant API Production (kg) by Application (2020-2025)

Table 58. Global Suvorexant API Production (kg) by Application (2026-2031)

Table 59. Global Suvorexant API Production Market Share by Application (2020-2025)

Table 60. Global Suvorexant API Production Market Share by Application (2026-2031)

Table 61. Global Suvorexant API Production Value (US$ Million) by Application (2020-2025)

Table 62. Global Suvorexant API Production Value (US$ Million) by Application (2026-2031)

Table 63. Global Suvorexant API Production Value Market Share by Application (2020-2025)

Table 64. Global Suvorexant API Production Value Market Share by Application (2026-2031)

Table 65. Global Suvorexant API Price (US$/kg) by Application (2020-2025)

Table 66. Global Suvorexant API Price (US$/kg) by Application (2026-2031)

Table 67. Merck Suvorexant API Company Information

Table 68. Merck Suvorexant API Specification and Application

Table 69. Merck Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 70. Merck Main Business and Markets Served

Table 71. Merck Recent Developments/Updates

Table 72. Biophore Suvorexant API Company Information

Table 73. Biophore Suvorexant API Specification and Application

Table 74. Biophore Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 75. Biophore Main Business and Markets Served

Table 76. Biophore Recent Developments/Updates

Table 77. Metrochem Suvorexant API Company Information

Table 78. Metrochem Suvorexant API Specification and Application

Table 79. Metrochem Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 80. Metrochem Main Business and Markets Served

Table 81. Metrochem Recent Developments/Updates

Table 82. Alembic Pharmaceuticals Suvorexant API Company Information

Table 83. Alembic Pharmaceuticals Suvorexant API Specification and Application

Table 84. Alembic Pharmaceuticals Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 85. Alembic Pharmaceuticals Main Business and Markets Served

Table 86. Alembic Pharmaceuticals Recent Developments/Updates

Table 87. Bajaj Healthcare Suvorexant API Company Information

Table 88. Bajaj Healthcare Suvorexant API Specification and Application

Table 89. Bajaj Healthcare Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 90. Bajaj Healthcare Main Business and Markets Served

Table 91. Bajaj Healthcare Recent Developments/Updates

Table 92. DEAFARMA Suvorexant API Company Information

Table 93. DEAFARMA Suvorexant API Specification and Application

Table 94. DEAFARMA Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 95. DEAFARMA Main Business and Markets Served

Table 96. DEAFARMA Recent Developments/Updates

Table 97. LifeFirst Pharma Suvorexant API Company Information

Table 98. LifeFirst Pharma Suvorexant API Specification and Application

Table 99. LifeFirst Pharma Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 100. LifeFirst Pharma Main Business and Markets Served

Table 101. LifeFirst Pharma Recent Developments/Updates

Table 102. Saptagir Laboratories Suvorexant API Company Information

Table 103. Saptagir Laboratories Suvorexant API Specification and Application

Table 104. Saptagir Laboratories Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 105. Saptagir Laboratories Main Business and Markets Served

Table 106. Saptagir Laboratories Recent Developments/Updates

Table 107. SMS Pharmaceuticals Suvorexant API Company Information

Table 108. SMS Pharmaceuticals Suvorexant API Specification and Application

Table 109. SMS Pharmaceuticals Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 110. SMS Pharmaceuticals Main Business and Markets Served

Table 111. SMS Pharmaceuticals Recent Developments/Updates

Table 112. Viatris Suvorexant API Company Information

Table 113. Viatris Suvorexant API Specification and Application

Table 114. Viatris Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 115. Viatris Main Business and Markets Served

Table 116. Viatris Recent Developments/Updates

Table 117. Zydus Lifesciences Suvorexant API Company Information

Table 118. Zydus Lifesciences Suvorexant API Specification and Application

Table 119. Zydus Lifesciences Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 120. Zydus Lifesciences Main Business and Markets Served

Table 121. Zydus Lifesciences Recent Developments/Updates

Table 122. Axplora Suvorexant API Company Information

Table 123. Axplora Suvorexant API Specification and Application

Table 124. Axplora Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 125. Axplora Main Business and Markets Served

Table 126. Axplora Recent Developments/Updates

Table 127. Apino Pharma Suvorexant API Company Information

Table 128. Apino Pharma Suvorexant API Specification and Application

Table 129. Apino Pharma Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 130. Apino Pharma Main Business and Markets Served

Table 131. Apino Pharma Recent Developments/Updates

Table 132. Conscientia Industrial Suvorexant API Company Information

Table 133. Conscientia Industrial Suvorexant API Specification and Application

Table 134. Conscientia Industrial Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 135. Conscientia Industrial Main Business and Markets Served

Table 136. Conscientia Industrial Recent Developments/Updates

Table 137. BSAZ Biotech Suvorexant API Company Information

Table 138. BSAZ Biotech Suvorexant API Specification and Application

Table 139. BSAZ Biotech Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 140. BSAZ Biotech Main Business and Markets Served

Table 141. BSAZ Biotech Recent Developments/Updates

Table 142. Sandoo Pharmaceutical Suvorexant API Company Information

Table 143. Sandoo Pharmaceutical Suvorexant API Specification and Application

Table 144. Sandoo Pharmaceutical Suvorexant API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 145. Sandoo Pharmaceutical Main Business and Markets Served

Table 146. Sandoo Pharmaceutical Recent Developments/Updates

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Suvorexant API Distributors List

Table 150. Suvorexant API Customers List

Table 151. Suvorexant API Market Trends

Table 152. Suvorexant API Market Drivers

Table 153. Suvorexant API Market Challenges

Table 154. Suvorexant API Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. Authors List of This Report

List of Figures

Figure 1. Product Picture of Suvorexant API

Figure 2. Global Suvorexant API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Suvorexant API Market Share by Type: 2024 VS 2031

Figure 4. Industrial Grade (98%-99.0%) Product Picture

Figure 5. Pharmaceutical Grade (99.0%-99.5%) Product Picture

Figure 6. High Purity Grade (Greater Than 99.5%) Product Picture

Figure 7. Global Suvorexant API Market Value by Synthesis Method, (US$ Million) & (2020-2031)

Figure 8. Global Suvorexant API Market Share by Synthesis Method: 2024 VS 2031

Figure 9. Fragment Splicing Method Product Picture

Figure 10. Linear Synthesis Method Product Picture

Figure 11. Global Suvorexant API Market Value by Drug Registration Classification, (US$ Million) & (2020-2031)

Figure 12. Global Suvorexant API Market Share by Drug Registration Classification: 2024 VS 2031

Figure 13. Original Drug Product Picture

Figure 14. Generic Drug Product Picture

Figure 15. Global Suvorexant API Market Value by Application, (US$ Million) & (2020-2031)

Figure 16. Global Suvorexant API Market Share by Application: 2024 VS 2031

Figure 17. Insomnia

Figure 18. Others

Figure 19. Global Suvorexant API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Suvorexant API Production Value (US$ Million) & (2020-2031)

Figure 21. Global Suvorexant API Production Capacity (kg) & (2020-2031)

Figure 22. Global Suvorexant API Production (kg) & (2020-2031)

Figure 23. Global Suvorexant API Average Price (US$/kg) & (2020-2031)

Figure 24. Suvorexant API Report Years Considered

Figure 25. Suvorexant API Production Share by Manufacturers in 2024

Figure 26. Global Suvorexant API Production Value Share by Manufacturers (2024)

Figure 27. Suvorexant API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 28. The Global 5 and 10 Largest Players: Market Share by Suvorexant API Revenue in 2024

Figure 29. Global Suvorexant API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 30. Global Suvorexant API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. Global Suvorexant API Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)

Figure 32. Global Suvorexant API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 33. North America Suvorexant API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 34. Europe Suvorexant API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 35. China Suvorexant API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 36. Japan Suvorexant API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 37. Global Suvorexant API Consumption by Region: 2020 VS 2024 VS 2031 (kg)

Figure 38. Global Suvorexant API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 39. North America Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 40. North America Suvorexant API Consumption Market Share by Country (2020-2031)

Figure 41. U.S. Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 42. Canada Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 43. Europe Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 44. Europe Suvorexant API Consumption Market Share by Country (2020-2031)

Figure 45. Germany Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 46. France Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 47. U.K. Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 48. Italy Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 49. Netherlands Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 50. Asia Pacific Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 51. Asia Pacific Suvorexant API Consumption Market Share by Region (2020-2031)

Figure 52. China Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 53. Japan Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 54. South Korea Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 55. China Taiwan Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 56. Southeast Asia Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 57. India Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 58. Latin America, Middle East & Africa Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 59. Latin America, Middle East & Africa Suvorexant API Consumption Market Share by Country (2020-2031)

Figure 60. Mexico Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 61. Brazil Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 62. Turkey Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 63. GCC Countries Suvorexant API Consumption and Growth Rate (2020-2031) & (kg)

Figure 64. Global Production Market Share of Suvorexant API by Type (2020-2031)

Figure 65. Global Production Value Market Share of Suvorexant API by Type (2020-2031)

Figure 66. Global Suvorexant API Price (US$/kg) by Type (2020-2031)

Figure 67. Global Production Market Share of Suvorexant API by Application (2020-2031)

Figure 68. Global Production Value Market Share of Suvorexant API by Application (2020-2031)

Figure 69. Global Suvorexant API Price (US$/kg) by Application (2020-2031)

Figure 70. Suvorexant API Value Chain

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Dual Orexin Receptor Antagonist Market Research Report 2024

Global Desvenlafaxine Succinate Extended release Tablets Market Research Report 2025

Global Granisetron HCl API Market Research Report 2024

Mestranol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tasimelteon Market Research Report 2025

Global Hydroxyzine Pamoate Oral Capsules Market Research Report 2024

Global Ramelteon Market Insights Forecast to 2030

Pegvisomant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Trimipramine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Granisetron Market Insights Forecast to 2030

Pegvisomant Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Melatonin Receptor Agonists Market Research Report 2025

Global Atosiban Market Insights Forecast to 2030

Global Mirabegron Reagent Market Research Report 2024

Global Sepantronium Bromide Market Research Report 2024

Global Mirabegron API Market Research Report 2024

Global Ambrisentantable Market Research Report 2024

Siponimod Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Somavert Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions